Update on 76471 RE: 76418 FDA Freedom of Information Act Appeal: FOIA 2024-5142
The information and concerns you shared in your messages were forwarded to the appropriate staff within FDA’s Center for Biologics Evaluation and Research (CBER).
More news from FDA
Following on from yesterday’s post below:
I received an email this morning as so:
“Dear Hedley:
Thank you for your follow-up message to the U.S. Food and Drug Administration (FDA). Your email has been forw…